Mad Money w/ Jim Cramer Mad Money w/ Jim Cramer 8/26/25
7 snips
Aug 26, 2025 Dive into the fascinating world of Wall Street as experts decode the influence of political events on stock prices. Discover the breakthroughs in pharmaceuticals with Eli Lilly’s new memory loss drug and how TJX defies market fluctuations with impressive earnings. Explore commodity market dynamics and their implications for agriculture, alongside an enticing glimpse into a luxury watch brand's NFL partnership. Plus, tackle economic challenges and the complexities of domestic production in a globalized market.
AI Snips
Chapters
Transcript
Episode notes
Stock Tips Between MRI Scans
- Jim Cramer recounts getting stock questions during an MRI and advising a woman to own Nvidia.
- He uses the story to show listeners want practical market guidance, not political lectures.
TJX: Conservative Guidance, Genuine Beat
- TJX's quarter showed accelerating revenue across divisions and strong margins, validating its off-price model.
- Management's conservative guidance plus consistent overperformance creates buyable rallies after earnings.
Add TJX After A Real Beat-And-Raise
- Consider buying TJX as a long-term retail winner after its strong quarter and margin expansion.
- Expect the stock to potentially remain on the new-high list given its share-gain opportunities and UPOD history.